Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet ...

Just over the last few months, MX908 was adopted into multiple global enterprise accounts, including the Vietnam Border Guard ...

Consisting of five separate booklets, the World Drug Report 2021 provides an in-depth analysis of the global drug markets and paints a comprehensive picture of the measurable effects and potential ...

Medico Remedies Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Labour Charges and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the ...